PANDA Therapeutics
PANDA Therapeutics is developing an antibody-based treatment designed to tackle multiple harmful protein deposits in the brain simultaneously.
PANDA Therapeutics has raised €160k across 1 funding round from 1 investor, most recently a round in Aug 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€160k
€159,983
Funding rounds
1
Investors
1
distinct backers
Active since
2026-08
latest 2026-08
Funding by year
EUR raised per year · 2026 YTDPANDA Therapeutics — funding by year — interactive chart.
Data table
| PANDA Therapeutics — funding by year | |
|---|---|
| 2026 | €160k |
Signals
High confidenceRaise-next likelihood14
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-31 | Other | €160k | Venture Kick | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData